These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

38 related articles for article (PubMed ID: 6714406)

  • 1. [Pharmacokinetics of 131I-streptokinase].
    Klöcking HP; Senf L; Drawert J; Markwardt F; Schmidt H
    Farmakol Toksikol; 1984; 47(2):54-6. PubMed ID: 6714406
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Animal experimental studies on the pharmacokinetics of streptokinase].
    Klöcking HP; Senf L; Drawert J; Markwardt F
    Acta Biol Med Ger; 1975; 34(4):655-60. PubMed ID: 1189839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of radioiodinated streptokinase.
    Coates G; DeNardo SJ; DeNardo GL; Troy FA
    J Nucl Med; 1975 Feb; 16(2):136-42. PubMed ID: 1110418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Animal experiments on the pharmacokinetics of ocrase (author's transl)].
    Markwardt F; Klöcking HP; Senf L; Schmidt HE; Drawert J; Herzmann H
    Pharmazie; 1979 Dec; 34(12):827-9. PubMed ID: 397495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Proceedings: Labeling and pharmacokinetics of 131-I-streptokinase].
    Schmidt HE; Herzmann H; Koehler M; Gerlach P; Markwardt F; Klöcking HP
    Radiobiol Radiother (Berl); 1975; 16(1):124-5. PubMed ID: 1215469
    [No Abstract]   [Full Text] [Related]  

  • 6. 211At- and 131I-labeled bisphosphonates with high in vivo stability and bone accumulation.
    Larsen RH; Murud KM; Akabani G; Hoff P; Bruland OS; Zalutsky MR
    J Nucl Med; 1999 Jul; 40(7):1197-203. PubMed ID: 10405142
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological study of the streptokinase preparation, avelizin].
    Markwardt F; Klöcking HP
    Farmakol Toksikol; 1980; 43(6):671-4. PubMed ID: 7450003
    [No Abstract]   [Full Text] [Related]  

  • 8. [Streptokinase will not be perorally reabsorbed].
    Fischbacher W
    Schweiz Med Wochenschr; 1967 Feb; 97(7):211-3. PubMed ID: 5589272
    [No Abstract]   [Full Text] [Related]  

  • 9. Plasminogen is a critical host pathogenicity factor for group A streptococcal infection.
    Sun H; Ringdahl U; Homeister JW; Fay WP; Engleberg NC; Yang AY; Rozek LS; Wang X; Sjöbring U; Ginsburg D
    Science; 2004 Aug; 305(5688):1283-6. PubMed ID: 15333838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [In vitro studies of various drug effects on streptokinase activity].
    Fuchs R
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1973; 100(3):290-4. PubMed ID: 4130626
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of radiolabeling monoclonal antibodies with a residualizing iodine radiolabel on the accretion of radioisotope in tumors.
    Stein R; Goldenberg DM; Thorpe SR; Basu A; Mattes MJ
    Cancer Res; 1995 Jul; 55(14):3132-9. PubMed ID: 7606734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution and placental transfer of 131-I streptokinase.
    Pfeifer GW
    Australas Ann Med; 1970; 19 Suppl 1():17-8. PubMed ID: 5482263
    [No Abstract]   [Full Text] [Related]  

  • 13. Longitudinal microSPECt/CT imaging and pharmacokinetics of synthetic luteinizing hormone-releasing hormone (LHRH) vaccine in rats.
    Chang CH; Hsu WC; Wang CY; Jan ML; Tsai TH; Lee TW; Lynn SG; Yeh CH; Chang TJ
    Anticancer Res; 2007; 27(5A):3251-8. PubMed ID: 17970068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melanoma affinity in mice and immunosuppressed sheep of [(125)I]N-(4-dipropylaminobutyl)-4-iodobenzamide, a new targeting agent.
    Labarre P; Papon J; Rose AH; Guerquin-Kern JL; Morandeau L; Wu TD; Moreau MF; Bayle M; Chezal JM; Croisy A; Madelmont JC; Turner H; Moins N
    Nucl Med Biol; 2008 Oct; 35(7):783-91. PubMed ID: 18848663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics, biodistribution, and dosimetry of specific and control radiolabeled monoclonal antibodies in patients with primary head and neck squamous cell carcinoma.
    Maraveyas A; Stafford N; Rowlinson-Busza G; Stewart JS; Epenetos AA
    Cancer Res; 1995 Mar; 55(5):1060-9. PubMed ID: 7866989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics of the venom of Bothrops erythromelas labeled with 131I in mice.
    Rocha ML; Valença RC; Maia MB; Guarnieri MC; Araujo IC; Araujo DA
    Toxicon; 2008 Sep; 52(3):526-9. PubMed ID: 18619993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Inhibition of esterase by L-lysine, the activator and fibrinolytic activity of the plasmin-streptokinase activator complex].
    Aĭsina RB; Gaĭsarian ES; Snitko IaE; Varfolomeev SD
    Bioorg Khim; 1994 Feb; 20(2):182-9. PubMed ID: 8155080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of anti-Lewis(y) humanized 3S193 radioimmunotherapy in a breast cancer model: enhanced activity when combined with taxol chemotherapy.
    Clarke K; Lee FT; Brechbiel MW; Smyth FE; Old LJ; Scott AM
    Clin Cancer Res; 2000 Sep; 6(9):3621-8. PubMed ID: 10999754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intratumoral distribution of radiolabeled antibody and radioimmunotherapy in experimental liver metastases model of nude mouse.
    Sato N; Saga T; Sakahara H; Yao Z; Nakamoto Y; Zhang M; Kuroki M; Matsuoka Y; Iida Y; Konishi J
    J Nucl Med; 1999 Apr; 40(4):685-92. PubMed ID: 10210230
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Distribution of 131I-labelled growth hormone in mice of high and low cancer lines].
    Patokin SV; Bobrov IuF; Dil'man VM
    Vopr Onkol; 1980; 26(1):77-9. PubMed ID: 7355602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 2.